Funded Tech Companies

Shinobi Therapeutics

Headquartered in San Francisco, Shinobi Therapeutics has funding from Astellas Venture Capital, D3 and Fast Track Initiative.

Company Overview

Company Name
Shinobi Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs. Shinobi uses the world's most comprehensive immune evasion technology to unlock the full potential of iPSCs. This is Shinobi, the first iPS cell therapy compatible with the patient's immune system. Shinobi's comprehensive immune evasion technology not only shields against T-cells and innate immunity, but also against antibody-mediated rejection.
Profile
Shinobi Therapeutics LinkedIn Company Profile
Social Media
Shinobi Therapeutics Company Twitter Account
Company News
Shinobi Therapeutics News
Facebook
Shinobi Therapeutics on Facebook
YouTube
Shinobi Therapeutics on YouTube
Last Transaction
12/12/2023

Financing History

Date
Type
Amount
Venture Equity
$51,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Kemp
  Daniel Kemp LinkedIn Profile  Daniel Kemp Twitter Account  Daniel Kemp News  Daniel Kemp on Facebook
Co-Founder
Tobias Deuse
  Tobias Deuse LinkedIn Profile  Tobias Deuse Twitter Account  Tobias Deuse News  Tobias Deuse on Facebook
Co-Founder
Shin Kaneko
  Shin Kaneko LinkedIn Profile  Shin Kaneko Twitter Account  Shin Kaneko News  Shin Kaneko on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Shinkei Systems | Shinydocs

 

Share this article

 


About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary